ON DEMAND WEBINAR
Duration: 1 hour​

GLP-1s and insulin are commonly prescribed to treat obesity and type 2 diabetes. But as costs climb, health plan and benefits leaders are asking: Do members need to stay on medications for life? And when is deprescription clinically appropriate? 

Join Virta for a candid conversation about how member-centered, evidence-based care can reduce or even eliminate reliance on costly medications that may no longer be needed or well tolerated. Hear three points of view on the value stepping down safely brings to members and the bottom line. You’ll learn:

• The clinical truth: What peer-reviewed evidence shows about deprescribing GLP-1s, and what outcomes are possible with a nutrition-first, drug-free approach 
• The member’s journey: What it’s like to be told a drug is “for life,” and what it means to successfully stop
• The business case: How focusing on disease reversal can drive cost savings, better health, and improved quality of life 

SPEAKERS

Robert Groves, MD
Former Health Plan CMO & Advisor, Risk Averse Health
 

Frank Dumont, MD, FACP
Senior Medical Director, Virta Health
 

Jim
Virta Member